The cytosolic free calcium in anti-μ-stimulated human B cells is derived partly from extracellular medium and partly from intracellular stores
Corresponding Author
Bernard Dugas
Roussel-UCLAF, Romainville
Departement des Biotechnologies, Roussel-UCLAF, 111 route de Noisy, F-93230 Romainville, FranceSearch for more papers by this authorAimé Vazquez
Department of Pathology, Brown University, Providence
Search for more papers by this authorCorresponding Author
Bernard Dugas
Roussel-UCLAF, Romainville
Departement des Biotechnologies, Roussel-UCLAF, 111 route de Noisy, F-93230 Romainville, FranceSearch for more papers by this authorAimé Vazquez
Department of Pathology, Brown University, Providence
Search for more papers by this authorAbstract
The inositol phospholipid metabolism and the increase in cytosolic free Ca2+ concentration ([Ca2+]i) into the cell are recognized as two important events in the anti-μ-induced B cell activation. The anti-μ stimulation caused the [3H]inositol incorporation and also a rapid increase in [Ca2+]i from 85 nM to 285 nM. This signal returned to baseline a few minutes after stimulation. By using the fluorescent indicator quin-2 we demonstrated that this [Ca2+]i uptake was derived part from extracellular medium and part from intracellular stores. Both EGTA (a calcium chelator) and TMB.8 (a drug which interferes with Ca2+ sequestration by smooth endoplasmic retiulum) partially suppressed the intracellular Ca2+ uptake and were fully inhibitory when added together. The role of Ca2+ from intracellular stores may also be evidenced in calcium-free experiments, or in permeabilized experiments using exogenous inositol 1,4,5-trisphosphate (IP3, the putative mobilizer of intracellular Ca2+). Preventing the increase in [Ca2+]i also prevents the apparition of early activation markers. These results are consistent with the hypothesis that the Ca2+ increase in B cells stimulated by anti-μ is caused by the generation of IP3 during the phosphatidyl-inositol metabolism and also by the entry of extracellular Ca2+ through the plasma membrane.
References
- 1 Melchers, F., Anderson, J., Lernhardt, W. and Schreier, M. H., Immunol. Rev. 1980. 52: 89.
- 2 Kishimoto, T., Immunol. Today 1983. 4: 117.
- 3 Howard, M. and Paul, W. E., Annu. Rev. Immunol. 1983. 1: 307.
- 4 Muraguchi, A., Butler, J. L., Kehrl, J. H. and Fauci, A. S., J. Exp. Med. 1983. 157: 30.
- 5 Parker, D. C., Fothergill, J. F. and Wadsworth, D. C., J. Immunol. 1979. 123: 931.
- 6 Fauci, A. S., J. Infect. Dis. 1982. 145: 602.
- 7 Cambier, J. C., Monroe, J. G., Coggeshall, K. M. and Ramson, J. T., Immunol. Today 1985. 6: 218.
- 8 Mond, J. J., Seghal, E., Kung, J. and Finkelman, F. D., J. Immunol. 1981. 127: 881.
- 9 Monroe, J. G. and Cambier, J. C., J. Exp. Med. 1983. 157: 2073.
- 10 Monroe, J. G. and Cambier, J. C., J. Immunol. 1983. 130: 626.
- 11 Cambier, J. C. and Monroe, J. G., J. Immunol. 1984. 133: 576.
- 12 Braun, J., Sha'afi, R. I. and Unanue, E. R., J. Cell. Biol. 1979. 82: 755.
- 13 Ramson, J. T. and Cambier, J. C., J. Immunol. 1986. 136: 66.
- 14 Ramson, J. T., Digiusto, D. L. and Cambier, J. C., J. Immunol. 1986. 136: 54.
- 15 Dugas, B., Vazquez, A., Delfraissy, J. F., Gerard, J. P., Rannou, M. T. and Galanaud, P., Eur. J. Immunol. 1986. 16: 162.
- 16 Paul, W. E., Mizuguchi, J., Brown, M., Nakanishi, K., Hornbeck, P., Rabin, E. and Ohara, J., Cell. Immunol. 1986. 99: 7.
- 17 Mishell, R. H. and Kirk, C. J., Trends Pharm. Sci. 1981. 2: 86.
- 18 Kishimoto, A., Takai, Y., Mori, T., Kikkawa, U. and Nishizuka, Y., J. Biol. Chem. 1980. 255: 2273.
- 19 Berridge, M. J., Biotechnology 1984. 2: 541.
- 20 Kriz, M. K., Vitetta, E. S. and Sullivan, T. J., J. Immunol. 1986. 137: 478.
- 21 Ku, Y., Kishimoto, A., Takai, Y., Ogawa, Y., Kimura, S. and Nishizuka, Y., J. Immunol. 1981. 127: 1375.
- 22 Nishizuka, Y., Nature 1984. 308: 693.
- 23 Farrar, W. L. and Ruscetti, F. W., J. Immunol. 1986. 136: 1266.
- 24 Dröge, W., Immunol. Today 1986. 7: 340.
- 25 Chen, Z. Z., Coggeshall, K. M. and Cambier, J. C., J. Immunol. 1986. 136: 2300.
- 26 Dugas, B., Vazquez, A., Klein, B., Delfraissy, J. F., Gerard, J. P., Rannou, M. T. and Galanaud, P., Eur. J. Immunol. 1986. 16: 1609.
- 27 Monroe, J. G. and Kass, M. J., J. Immunol. 1985. 135: 1674.
- 28 Clevers, J. C., Versteegen, J. M. T., Logtenberg, T., Gmelig-Meyling, F. H. J. and Bailleux, R. C., J. Immunol. 1985. 135: 3827.
- 29 Klaus, G. G. B., O'Garra, A., Bijsterbosch, M. K. and Holman, M., Eur. J. Immunol. 1986. 16: 92.
- 30 Sell, S., Rowe, D. S. and Gell, P. G. H., J. Exp. Med. 1965. 122: 823.
- 31 DeFranco, A. L., Raveche, E. S., Asofsky, R. and Paul, W. E., J. Exp. Med. 1982. 132: 176.
- 32 Muraguchi, A., Kehrl, J. H., Butler, J. L. and Fauci, A. S., J. Immunol. 1984. 132: 176.
- 33 Kehrl, J. H., Muraguchi, A. and Fauci, A. S., Eur. J. Immunol. 1984. 14: 115.
- 34 Wetzel, G. D., Swain, S. L., Dutton, R. W. and Kettman, J. R., J. Immunol. 1984. 133: 2327.
- 35 De Franco, A. L., Raveche, E. S. and Paul, W. E., J. Immunol. 1985. 135: 87.
- 36 Birx, D. L., Berger, M. and Fleischer, T. A., J. Immunol. 1984. 133: 2904.
- 37 Mills, G. B., Cheung, R. K., Grinstein, S. and Gelfand, E. W., J. Immunol. 1985. 134: 1640.
- 38 La Baer, J., Tsien, R. Y., Fahey, K. A. and De Franco, A. L., J. Immunol. 1986. 137: 1836.
- 39 Imboden, J. B. and Stobo, J. D., J. Exp. Med. 1985. 161: 446.
- 40 Nachshen, D. A., Pfeffer, L. M. and Tamm, I., J. Biol. Chem. 1986. 261: 15134.
- 41 Pozzan, T., Arslan, P., Tsien, R. Y. and Rink, T. J., J. Cell. Biol. 1982. 94: 335.
- 42 Thiele, D. L. and Lipsky, P. E., J. Immunol. 1985. 134: 786.
- 43 Reinherz, E. L., Penta, A. C., Hussey, R. E. and Schlossman, S. F., Clin. Immunol. Immunopathol. 1981. 21: 257.
- 44 Tsien, R. Y., Pozzan, T. and Rink, T. J., J. Cell. Biol. 1982. 94: 325.
- 45 Streb, H., Irvine, R. F., Berridge, M. J. and Schulz, I., Nature 1983. 306: 67.
- 46 Thomas, A. P., Alexander, J. and Williamson, J. R., J. Biol. Chem. 1984. 259: 5574.
- 47 Berridge, M. J., Dawson, R. M. C., Downes, C. P., Heslop, J. P. and Irvine, J. B., Biochem. J. 1983. 212: 473.
- 48 Kehrl, J. H., Muraguchi, A. and Fauci, A. S., J. Immunol. 1984. 132: 2857.
- 49 Muraguchi, A., Kehrl, J. H., Butler, J. L. and Fauci, A. S., J. Clin. Immunol. 1984. 4: 337.
- 50 Melchers, F. and Andersson, J., Cell 1984. 37: 715.
- 51 Klaus, G. G. B. and Hawrylowicz, C. M., Immunol. Today 1984. 5: 15.
- 52 Dugas, B., Vazquez, A., Gerard, J. P., Richard, Y., Auffredou, M. T., Delfraissy, J. F., Fradelizi, D. and Galanaud, P., J. Immunol. 1985. 135: 333.
- 53 Vazquez, A., Gerard, J. P., Delfraissy, J. F., Dugas, B., Auffredou, M. T., Crevon, M. C., Fradelizi, D. and Galanaud, P., Eur. J. Immunol. 1986. 16: 803.
- 54 Wolf, M., Levine II, H., May, J. S., Cuatrecasas, P. and Shayoun, N., Nature 1985. 317: 546.
- 55 May, J. S., Shayoun, N., Wolf, M. and Cuatrecasas, P., Nature 1985. 317: 549.
- 56 Greene, W. C., Parker, C. M. and Parker, C. W., Cell. Immunol. 1976. 25: 74.
- 57 Grinstein, S. and Cohen, S., J. Gen. Physiol. 1987. 89: 185.
- 58 Zavoico, G. B., Halenda, S. P., Sha'afi, R. I. and Feinstein, M. B., Proc. Natl. Acad. Sci. USA 1985. 82: 3859.
- 59 Irvine, R. F., Letcher, A. J., Heslop, J. P. and Berridge, M. J., Nature 1986. 323: 112.
- 60 Batty, A. R., Nahorski, S. R. and Irvine, R. F., Biochem. J. 1985. 232: 211.
- 61 DeFranco, A. L., Gold, M. R. and Jakway, J. P., Immunol. Rev. 1987. 95: 161.
- 62 Joseph, S. K., Thomas, A. P., Williams, R. F., Irvine, R. F. and Williamson, J. R., J. Biol. Chem. 1984. 259: 3077.
- 63 Burgess, G. M., Godfrey, P. P., McKinney, J. S., Berridge, M. J., Irvine, R. F. and Putney, J. W., Nature 1984. 309: 63.
- 64 Prenki, M., Biden, T. J., Janjic, D., Irvine, R. F., Berridge, M. J. and Wolheim, C. B., Nature 1984. 309: 562.
- 65 Ransom, J. T., Harris, L. K. and Cambier, J. C., J. Immunol 1986. 137: 708.
- 66 Cambier, J. C., Justement, L. B., Newell, M. K., Chen, Z. Z., Harris, L. K., Sandoval, V. M., Klemsz, M. J. and Ransom, J. T., Immunol. Rev. 1987. 95: 37.
- 67 Bijsterbosch, M. K., Meade, C. J., Turner, G. A. and Klaus, G. G. B., Cell 1985. 41: 999.